The Entheogenic Origins of Religion and the Sacramental Science of Cognitive Restoration

(The website has been rapidly populated with text derived from notes while work is focused on the research effort. Future Updates will seek to clarify and improve the specific language presented on the website, It is being made available now in its current form due to the urgency implied by its inherent findings)

The Universal Teaching Schedule of Antiquity

A rigorous forensic reconstruction of human spiritual history reveals a profound, systematic continuity at the genesis of human civilization. The origin of all worldly religions does not stem from isolated, primitive superstitions, but rather from a single, unified teaching schedule regarding the alignment and purification of the human brain itself. Ancient MYSTERY SCHOOLS, indigenous tribes, and esoteric organizations developed a highly functional, biologically grounded science of consciousness. This ancient tradition utilized specific, potent entheogenic compounds as sacramental technology to dissolve COGNITIVE RIGIDITY, restore the innate ability to reason, and allow the initiate to directly "come to know god" through unmediated experiential gnosis.

The successors of these ancient teachings—ranging from the Egyptian priesthood and Vedic Brahmins to the Eleusinian hierophants, the initiates of Mithra, the Sufi mystics of the Islamic world, and the spiritual leaders of Mesoamerica—all utilized various forms of entheogenic compounds to facilitate this neurological transformation. However, as the original, experiential core of these teachings was progressively co-opted by state-aligned orthodoxies and commercial-priestly monopolies, the esoteric biological technologies were deliberately suppressed. In their place, these traditions were corrupted into exoteric forms: dogmatic shells demanding blind belief and literalist obedience rather than facilitating direct neurological transformation.

By painting a comprehensive historical picture, it becomes evident that all entheogens are, by proxy, associated with the origins of all worldly religions in their historic realms of practice, though this reality has been heavily buried by a long history of book destruction and the targeted killings of the very people who harbored the knowledge of their use. Readers seeking a deeper understanding of how these original experiential teachings were systematically distorted into rigid, exoteric power structures are strongly directed to explore the specific section on "Religion" found on the website hosting this content.

The Pathology of the Uninitiated Mind: Psycho-Vulgarism

To fully grasp the necessity of ancient sacramental technology, one must understand the biological default state of the uninitiated human brain. This condition of COGNITIVE RIGIDITY, which the ancient MYSTERY SCHOOLS sought to cure, is classified in modern analytical frameworks as Psycho-Vulgarism (PV). PV is a proposed neurologically-grounded condition wherein the brain's capacity for genuine, objective reasoning becomes functionally subordinate to the automatic defense of identity-defining beliefs.

When the drives engaged by a question are running in their biophilic direction, new information is evaluated against sensory evidence, and a conclusion is reached based on that objective evaluation. In a mind afflicted with PV, this sequence is structurally reversed. HSRP-020 When a person encounters information that conflicts with a belief they have fused with their identity, the brain's survival circuitry activates. The dual-route architecture was established in animals — Quirk, Repa & LeDoux (Neuron 15:1029–1039, 1995)[1] found fear-conditioning effects in response components arriving too early to have passed through cortex. Those are rodent auditory values and should not be quoted as human figures. ESTABLISHED The human evidence came later: Mendez-Bertolo et al. (Nature Neuroscience 19:1041–1049, 2016)[2] recorded depth electrodes in eleven epilepsy patients and found amygdala responses beginning 74 milliseconds after stimulus onset to fearful faces — before visual cortex, and selective to low spatial frequency exactly as a subcortical pathway predicts. A second study replicated this at 88 milliseconds for backward-masked faces the subject could not consciously perceive (J. Neurosci. 43:1405, 2023).[3] HSRP-310 ESTABLISHED The model was seriously challenged by Pessoa and Adolphs (Nature Reviews Neuroscience 11:773–783, 2010)[4], who proposed a "multiple waves" account instead CONTESTED; the intracranial studies above answered that challenge directly. This subcortical pathway registers the conceptual challenge as a mortal biological threat long before the thalamo-cortical pathway can consciously evaluate the data.

Consequently, the conclusion is pre-locked by the threat-response system before reasoning even begins. The brain's language and analytical centers then activate strictly to construct a post-hoc justification for rejecting the threatening information. This mechanism is executed by the left-hemisphere "Interpreter," a neural system extensively documented by neuroscientist Michael S. Gazzaniga during decades of split-brain research. The Interpreter confabulates a coherent, plausible narrative that the individual subjectively experiences as genuine "reasoning," despite the fact that it is a structurally BACKWARD RATIONALIZATION built entirely to protect the ego.

This neurorigidity is heavily cemented during childhood and adolescence, a critical developmental window when neuroplasticity is heightened but the prefrontal cortex's capacity for independent evaluation remains immature. HSRP-044 HSRP-257 Beliefs installed by authority figures during this period become load-bearing identity structures. At a civilizational scale, this mechanism is exploited by the "Authoritarian Blueprint," an institutional information-dominance strategy that maximizes manufactured noise to control the evidentiary thresholds of a population. HSRP-163 HSRP-174 The result is a society locked in institutional necrophilia, entirely insulated from updating its models of reality.

The Hermetic Science of Rebirth: Palingenesia

The ancient science designed to dismantle this neurological rigidity is most explicitly articulated in the surviving texts of the Hellenistic-Egyptian wisdom tradition. The central operational concept within this tradition is PALINGENESIA (Greek: παλιγγενεσία, from palin meaning "again" and genesis meaning "birth" or "becoming"). HSRP-345 In the mystery traditions, palingenesia was not a vague metaphor for moral improvement; it was a highly specific, technical term denoting a profound neurological and psychological threshold-crossing that fundamentally altered the mind and understanding.

The Corpus Hermeticum, specifically Tractate XIII ("The Discourse on Rebirth"), provides a complete schematic of this restorative process. The text details how the uninitiated human mind is governed by twelve "irrational tormentors" or archonic drives, which correspond to the structural conditioning of the human nervous system. HSRP-355 The application of the PALINGENESIA forcibly expels these rigid, conditioned drives—which include ignorance, grief, intemperance, desire, injustice, and deceit—and replaces them with ten divine powers, including self-knowledge, joy, continence, and truth. HSRP-353 HSRP-354 This transformation produces the Ogdoadic nature, a state of profound cognitive clarity and boundless reason achieved through the silencing of the egoic narrative. HSRP-352

This exact terminology and structure echo across parallel ancient texts. In the canonical New Testament, the concept is preserved in Titus 3:5, which speaks of salvation through the "washing of PALINGENESIA," and in Matthew 19:28, which connects the palingenesia directly to the mastery of the twelve drives, symbolized esoterically as the twelve tribes.[26] HSRP-346 Furthermore, the Gospel of Philip, a text preserved in the Nag Hammadi library, explicitly identifies the true completing sacrament not as mere water baptism, but as the "chrism" (anointing)—a biological sacrament described as sealing the initiate against the attacks of the archons and restoring the primordial cognitive state in the "bridal chamber."[27] HSRP-372

The Legal Context of Sacramental Technology

As the following sections will detail the specific entheogenic compounds utilized throughout history to achieve PALINGENESIA, a critical clarification regarding the scope of this report is necessary.

The historic use of these substances as illustrated throughout this website should be considered alongside the sections regarding NATIONAL SECURITY and NATURAL LAW.

These sections exhaustively detail how modern jurisprudence touches upon the use of these sacraments, the history of their scheduling, and the application of frameworks such as NATURAL LAW, the reservations of the United States during the 1971 Convention on Psychotropic Substances, the Paramount Trust Doctrine, the Religious Freedom Restoration Act (RFRA), which has been utilized in landmark Supreme Court cases (e.g., Gonzales v. O Centro Espírita Beneficente União do Vegetal)[28] to protect specific sacramental practices.

The Universal Pharmacopoeia: Entheogens as Neuroplastic Sacraments

The successors of the ancient teachings deployed a vast pharmacopoeia of NEUROPLASTIC agents across the globe. Each compound functioned as a catalyst to suppress the Default Mode Network (DMN)—the brain's prior-belief enforcement system—and induce structural neuroplasticity, opening a window in which change becomes possible. HSRP-277 HSRP-368

Sacrament / Compound Primary Active Agents Core Neurobiological Mechanism Historic Traditions & Mystery Schools
Kykeon Ergot alkaloids (LSA, ergine) Serotonin 5-HT2A agonism, DMN suppression Eleusinian Mysteries (Greece)
Dionysian Wine Nightshades, Ergot derivatives Mixed 5-HT2A agonism, anticholinergic Cults of Dionysus, Bacchus, Mithra
Egyptian Sacrament Nuciferine, Apomorphine, Harmala alkaloids D1/D2 agonism, MAOI, BDNF/VMAT-2 upregulation Egyptian Priesthood, Ptolemaic Cults
Psilocybin / Prodrugs Psilocin, 4-AcO-DMT, 4-HO-MET 5-HT2A agonism, TrkB binding, BDNF increase Mesoamerican Priests (Aztec/Maya)
Ayahuasca N,N-DMT, Harmine, Harmaline 5-HT2A agonism, MAO inhibition, BDNF increase Amazonian Tribes, Santo Daime, UDV
Ibogaine Ibogaine GDNF upregulation, NMDA antagonism Bwiti Tradition (Central Africa)
Mescaline Mescaline 5-HT2A agonism Andean (San Pedro), Native American
Amanita muscaria Muscimol, Ibotenic acid GABA-A δ-subunit agonism, NMDA Siberian Shamans, Vedic Soma (proposed)

The Four Components

The sacrament is one of four components. The others are context, the guide and integration. The sections that follow describe the sacraments. This section describes what the sacraments do not supply on their own. HSRP-027

The compound is permissive, not instructive. It makes change possible. Something else supplies the change. Six independent demonstrations stand behind this. In each one, the effect depended on something supplied alongside the drug: extinction training, visual input, ongoing activity, or deprivation. HSRP-277

The window closes. How long it stays open tracks how long the acute effects last: roughly 48 hours for ketamine, up to two weeks for MDMA, more than a month for ibogaine. HSRP-278

A single administration is not a course of treatment. Trials typically administer more than once. No evidence supports one session producing a durable outcome. HSRP-287

The guide functions as the external reality anchor. While the subject's attribution machinery is offline, the guide is the one unambiguously external source held stable. HSRP-298

Content that surfaces in a session is significant. It is not evidence. The sense of realness that comes with it is pharmacologically amplified. A guide who treats surfaced content as established autobiographical fact repeats the error of the memory wars. HSRP-299

Order matters, and the right order is not established. Drug timing relative to memory retrieval determines the outcome, and the direction differs from compound to compound. No classic psychedelic has been tested in that design. HSRP-281

Integration has no controlled evidence. 84% of people with adverse psilocybin experiences outside clinical settings reported positive long-term outcomes without it. HSRP-285

The established predictors of outcome do not include control, agency or self-efficacy. The nearest is a therapist-rated belief in an active mode of therapeutic action. HSRP-286

The sacrament opens a window. The other three components decide what the window is used for, and how much of what surfaces inside it should be believed.

The Eleusinian Kykeon and Ergot Alkaloids

For nearly two millennia, the Eleusinian Mysteries served as the spiritual apex of the Greco-Roman world, initiating the most profound thinkers of antiquity. Initiates partook of the kykeon, a sacramental beverage whose exact composition was a closely guarded secret. That the kykeon contained ergot (Claviceps purpurea), a fungus that grows on barley and contains lysergic acid amide (LSA/ergine), is a hypothesis, not a confirmed finding. It was proposed by R. Gordon Wasson, Albert Hofmann and Carl A. P. Ruck in The Road to Eleusis (1978),[22] and it was widely rejected: Walter Burkert questioned the quantities needed for thousands of participants, and noted that ergot poisoning "is normally described as quite an unpleasant and not at all a euphoric state."[23] Brian Muraresku revived the case in The Immortality Key.[17] The material evidence so far comes not from Eleusis but from Mas Castellar de Pontós, an Iberian settlement in Catalonia near the Greek colony of Emporion, where fragments of ergot were identified inside a ceremonial vessel and in the dental calculus of a 25-year-old man, at a site interpreted as a sanctuary of Demeter and Persephone.[24] At Eleusis itself no ergot residue has been found — but no systematic residue analysis has ever been permitted there.[25] The hypothesis now has supporting evidence, from a different site. HSRP-356

On that hypothesis, ancient priestesses utilized sophisticated ash and lye-treatment methods to separate the psychoactive ergot alkaloids from toxic ergopeptides, producing a powerful 5-HT2A agonist.[25] HSRP-370 This compound was capable of inducing profound ego dissolution and neuroplasticity. The undeniable efficacy of this sacrament is evidenced by the first-person attestations of its initiates, who numbered among the greatest minds of the ancient world. Pindar (c. 518-438 BCE) wrote, "Blessed is he who has seen these things before he goes beneath the hollow earth; for he understands the end of mortal life."[29] Sophocles and Plato similarly recorded the profound, paradigm-altering visions achieved through the Greater Mysteries, confirming that these experiences restored a higher cognitive function and dispelled the fear of death.

Dionysian Pharmakon, Bacchic Rites, and Mithraic Mysteries

Operating parallel to Eleusis, the MYSTERY SCHOOLS of Dionysus, Bacchus, and Mithra utilized spiked wines (pharmakon) engineered to induce non-ordinary states of consciousness. These sacramental wines were routinely fortified with psychoactive botanical additives, prominently including nightshade plants (such as henbane, datura, and belladonna), as well as ergot derivatives. Evidence preserved by botanical authorities such as Dioscorides documents specific ancient recipes for these psychoactive wine preparations.[30]

The cult of Mithra, highly popular among the Roman military, utilized a strictly graded seven-stage initiatic structure (Corax through Pater)[31][32], wherein access to the sacramental meal was restricted only to those who had reached advanced levels of psychological preparation. HSRP-369 These sacraments suppressed rigid cortical control and induced states of visionary receptivity, functioning as biological tools to break the localized PV conditioning and societal programming of the era.

The Egyptian Sacrament: Blue Lotus and Syrian Rue

The spiritual technologies of the Egyptian priesthood were long shrouded in mythological allegory, but multidisciplinary scientific analyses have unmasked their pharmacological reality. A landmark 2024 study published in Scientific Reports analyzed a 2,000-year-old Ptolemaic ritual vase adorned with the head of the god Bes, currently housed at the Tampa Museum of Art. Employing cutting-edge proteomics, metabolomics, genetics techniques, and synchrotron radiation-based Fourier Transformed Infrared microSpectroscopy, researchers led by Davide Tanasi revealed the presence of a highly complex psychedelic cocktail.[5] HSRP-035

The vessel contained residues of Nymphaea caerulea (Egyptian blue lotus) and Peganum harmala (Syrian rue), alongside species of the Cleome genus. The blue lotus provides the alkaloids nuciferine and apomorphine, the latter acting as a D1/D2 agonist with documented BDNF and VMAT-2 neuroprotective action. Syrian rue provides the potent β-carboline MAO inhibitors harmine and harmaline, which independently promote structural neuroplasticity. Combined with traces of fermented fruit, honey, human blood, and human breast milk, this mixture proves that the Egyptian priesthood engineered specific, highly advanced chemical interactions. These sacraments were utilized in magical and spiritual practices—specifically within the Bes Chambers at Saqqara—to achieve altered states of consciousness, facilitate mystical-ritual experiences, and induce dream-vision states that mitigated the psychological rigidities of the mundane world.

Psilocybin Mushrooms and Synthesized Prodrugs

Mesoamerican priesthoods, prominently including those of the Aztec and Maya civilizations, utilized Psilocybe mushrooms (teonanácatl, literally "flesh of the gods") as a central pillar of their spiritual and educational systems. In modern neuroscience, psilocybin has emerged as the most extensively studied psychedelic for the treatment of severe cognitive and depressive disorders. Psilocybin is a phosphorylated prodrug that rapidly dephosphorylates in vivo into the active metabolite psilocin (4-HO-DMT).

Psilocin is a highly potent 5-HT2A agonist that triggers massive desynchronization of the DEFAULT MODE NETWORK. A comprehensive 2024 study by Siegel, Dosenbach and colleagues demonstrated that psilocybin disrupts connectivity across cortical networks, producing more than a threefold greater acute change in functional networks than standard stimulants, dissolving network distinctions by reducing correlations within the DMN.[6] HSRP-019 Concurrently, psilocin directly binds to TrkB receptors (independently of 5-HT2A activation)[9] to stimulate Brain-Derived Neurotrophic Factor (BDNF) signaling, inducing rapid and persistent dendritic spine growth in the frontal cortex.[10] HSRP-009 The effect on rigidity itself has now been measured, and the result is more specific than a cure.

In an open-label trial, twenty-four patients with major depression received roughly eight hours of preparatory therapy and two psilocybin sessions. Cognitive flexibility — measured as perseverative errors on a set-shifting task — improved significantly and remained improved at four weeks. The effect was selective: response inhibition, selective attention and abstract reasoning were unchanged. It was not a practice effect; a delayed control group took the same test twice beforehand with no change.[36] HSRP-377

Three things about that result matter more than the headline.

First, the improvement in flexibility was not correlated with the improvement in depression. Both improved; they moved independently. Rigidity appears to be a separate axis from mood, which is what this framework has assumed and had not previously been able to show.

Second, more plasticity was not better. Patients whose neural flexibility increased most showed the least improvement in cognitive flexibility, and patients with higher baseline neural flexibility improved least of all. The authors suggest psilocybin can push neural flexibility past the zone of largest therapeutic efficacy. This is an optimum, not a maximum — the same shape found across the plasticity literature. HSRP-290

Third, during the acute experience these compounds impair cognitive flexibility rather than improving it. LSD has been shown to acutely impair executive function and flexibility in humans.[37] Whatever improvement occurs, occurs afterwards, in the window.

A companion study makes the condition explicit: twelve healthy adults given a single dose with no therapy showed no enduring change in neural flexibility at one week or four weeks.[38] Patients, two doses, eight hours of preparation — four weeks of improvement. Healthy volunteers, one dose, no preparation — nothing. HSRP-027

The investigators' own reading is the one this page has argued throughout: the compound may "open a window of plasticity during which improvements can be facilitated," and they add that it remains speculative. They go further still, noting that a trivial dose of psilocybin combined with the same psychotherapy produced considerable reductions in depression. HSRP-277

To ensure this list of entheogens is as complete as possible, it is critical to recognize the known, modern synthesized prodrugs of psilocin, which operate via identical biological mechanisms. 4-Acetoxy-N,N-dimethyltryptamine (4-AcO-DMT, also known as psilacetin or O-acetylpsilocin) is a synthetic derivative in which the phosphate ester of psilocybin has been replaced with an acetate ester. Developed originally by Albert Hofmann in 1963 and refined by David E. Nichols in 1999, 4-AcO-DMT acts as a highly stable prodrug that metabolizes directly into psilocin in the human body. In vivo work confirms psilacetin acts as a psilocin prodrug, with the psilocin half-life holding at roughly thirty minutes whichever compound it came from. Exposure is not equivalent, however: at equimolar doses psilacetin produced approximately 30% less psilocin exposure than psilocybin, with psilocybin reaching 10-25% higher psilocin concentrations fifteen minutes after administration. Equal exposure required a psilacetin dose roughly 30% larger in molar terms.[33] HSRP-367

Two limits the authors state themselves. Pharmacodynamically equivalent doses are not likely to match the pharmacokinetically equivalent ones measured here, so the exposure ratio should not be read as a dosing conversion. And the salt form matters — the study used the fumarate; the hemifumarate would require its own adjustment for the half-weight of fumarate per molecule.

The work was conducted in male and female C57Bl6/J mice by intraperitoneal injection. No human clinical pharmacokinetic study of psilacetin has been published.

Because it yields the exact same active molecule, 4-AcO-DMT produces the identical NEUROPLASTIC outcomes—critical period reopening, ego dissolution, and BDNF upregulation—while often reportedly reducing the somatic nausea associated with consuming raw fungal biomass. Other homologous synthetic tryptamines, such as 4-HO-MET (metocin), further demonstrate the precision with which the tryptamine structure can be chemically optimized to reliably target the neurological foundations of PV.

Ayahuasca and the Amazonian Tradition

Indigenous Amazonian tribes, alongside modern syncretic religious organizations such as the Santo Daime and the União do Vegetal (UDV), have continuously utilized ayahuasca as a sacramental technology. This decoction combines N,N-DMT (derived from the leaves of Psychotria viridis) with β-carboline MAO inhibitors (derived from the vine Banisteriopsis caapi).

Because DMT is rapidly broken down by monoamine oxidase in the human gut, it is orally inactive on its own. The MAOIs in the caapi vine inhibit this breakdown, allowing the 5-HT2A agonist to cross the blood-brain barrier. Once active in the brain, the compound induces profound DMN suppression and acute, measurable serum BDNF increases, facilitating deep neuroplasticity.

Whether that plasticity can be used to revise traumatic memory is a separate question, and it is open. Reactivating a fear memory under a drug does not reliably weaken it — under ketamine, a single reactivation produced a stronger memory than placebo, in proportion to the individual's vulnerability to that drug's psychotogenic effects. HSRP-280 The direction is compound-specific and has not been established for any classic psychedelic, ayahuasca included. HSRP-281 And what surfaces under these compounds is not reliably what happened: psilocybin and 2C-B impair recollection while increasing false recognition, most strongly for emotionally charged material — the exact class that surfaces in this work. HSRP-284

The plasticity is real. What it is used for is decided by the other three components, not by the compound. HSRP-027

The profound spiritual and psychological utility of this sacrament has been recognized by the United States Supreme Court, which upheld the UDV's right to import and utilize ayahuasca under the Religious Freedom Restoration Act, noting the government's failure to demonstrate a compelling interest in suppressing its bona fide religious use.[28]

Ibogaine and the Bwiti Tradition

Originating in the Bwiti spiritual tradition of Central Africa (specifically Gabon, Cameroon, and the Congo Basin), the root bark of the Tabernanthe iboga shrub is utilized in multi-day ceremonies for initiation, healing, and ancestral communication. The isolated alkaloid, ibogaine, operates via a distinct neuropharmacological mechanism compared to classical serotonergic psychedelics. It acts as an NMDA antagonist and interacts with sigma-2 and kappa-opioid receptors, while inducing a massive, self-sustaining autoregulatory upregulation of Glial Cell Line-Derived Neurotrophic Factor (GDNF) and BDNF in the ventral tegmental area. HSRP-279 HSRP-262

A groundbreaking 2023 study published in Nature by Nardou et al. demonstrated that ibogaine reopens the social reward learning critical period for the longest duration of any compound tested[7]—keeping the NEUROPLASTIC window open for up to four weeks from a single dose. HSRP-287 HSRP-278 HSRP-290 Furthermore, rigorous clinical studies, such as the Stanford MISTIC trial (2024) treating special operations veterans with traumatic brain injuries, showed an 88% reduction in PTSD symptoms within one month of an ibogaine protocol, with 71% no longer meeting diagnostic criteria at one year.[8] HSRP-034 Ibogaine provides an unparalleled mechanism for "rewiring" the rigid, dopaminergic neural circuits that sustain severe PV expressions and addiction.

Mescaline-Bearing Cactuses

The San Pedro cactus (Echinopsis pachanoi) of the Andes and the Peyote cactus (Lophophora williamsii) of Mesoamerica contain mescaline, a highly potent 5-HT2A agonist belonging to the phenethylamine class. With an archaeological and ceremonial record stretching back over 3,000 to 5,000 years[34], these sacraments are central to the practices of indigenous groups and the modern Native American Church. HSRP-371 Mescaline produces the same fundamental structural neuroplasticity and DMN suppression seen in tryptamines, but with a longer duration of action, providing a slow-acting, deeply integrated dismantling of identity-protective cognitive blocks. HSRP-293

Amanita muscaria and the Vedic Soma

Extensively documented among pre-historical Siberian shamanic traditions, and proposed by scholars such as R.G. Wasson as the original identity of the Vedic Soma, the Amanita muscaria (Fly Agaric) mushroom utilizes a completely distinct neuropharmacological pathway. HSRP-049 Its active compounds, ibotenic acid and muscimol, bypass the serotonin system entirely. Muscimol acts as a potent, highly selective agonist at the extrasynaptic δ-subunit of the GABA-A receptor, which is primarily concentrated in the thalamus. HSRP-201

By inhibiting the thalamic relay (a critical node in the brain's "Gateway Network"), muscimol radically alters consciousness and sensory processing. This mechanism is entirely distinct from standard benzodiazepine sedatives, which target synaptic γ-receptors. This alternative biological mechanism provides a different, dissociative pathway for disrupting the uninitiated, rigid mind, validating the use of the sacrament in Arctic and sub-Arctic cultures.

The Architecture of Institutional Suppression

The suppression of these sacramental practices is not a modern anomaly; it is a continuously executed strategy by necrophilic institutional structures spanning over two millennia. When a society's populace utilizes biological technology that restores autonomous cognitive function and dissolves manufactured consensus, the authoritarian institutions that rely on PV for compliance face an existential threat. History records a relentless, organized campaign to target and destroy the practitioners of these arts.

The Roman Empire: From the Bacchanalia to the Theodosian Decrees

The earliest explicitly documented legal suppression of NEUROPLASTIC sacrament use occurred in 186 BCE under the Roman Republic. As the mysteries of Bacchus spread rapidly through central and southern Italy, they offered non-state-sanctioned spiritual initiation and ecstatic liberation from the rigid social hierarchies of Rome. Viewing this as a threat to the state's security and moral order, the Roman Senate issued the Senatus consultum de Bacchanalibus. This bronze-inscribed decree strictly outlawed the Bacchanalian cult across Italy, initiating a brutal wave of persecution. According to the historian Livy, the Senate executed over 6,000 practitioners, dismantled their shrines, and imposed the death penalty on the cult's leadership.

Centuries later, as the Roman Empire consolidated its power under an institutionalized Christian orthodoxy, it engaged in a totalizing campaign to eradicate the remaining ancient MYSTERY SCHOOLS. Emperor Theodosius I issued a series of sweeping decrees (recorded in the Codex Theodosianus 16.10.10 and 16.10.11) between 389 and 392 CE. These laws established a practical ban on all pagan religious rites, closed the temples, and strictly prohibited both public and private sacrificial offerings, making the practice of the ancient rites a capital offense. This systematic legal oppression culminated in the physical destruction of the sanctuary at Eleusis by fanatic mobs in 396 CE, successfully severing the institutional transmission of the kykeon sacrament that had enlightened the Mediterranean world for 2,000 years.

The Catholic Church and the Spanish Inquisition

The authoritarian blueprint established by Rome was carried forward by the institutional Church. During the Middle Ages, groups that preserved fragments of the inner initiatic tradition were violently suppressed. The Albigensian Crusade (1209–1229 CE) targeted the Cathars in the Languedoc region, resulting in mass executions and the burning of the library of Beziers. Shortly after, the Knights Templar were tortured, dissolved, and burned at the stake by the French Crown and the Papacy (1307–1314 CE).

When the Spanish Empire invaded the Americas, the Inquisition was immediately deployed against the sacramental priesthoods of Mesoamerica. The Spanish authorities recognized that the Aztec and Maya educational systems—such as the calmecac schools for advanced initiates—and their use of entheogenic mushrooms (teonanácatl) directly challenged the dogmatic monopoly of the Church. In an effort to annihilate their cultural memory and scientific knowledge, Juan de Zumárraga burned vast archives of Aztec manuscripts in Mexico City in 1529. Decades later, in 1562, Franciscan friar Diego de Landa held a horrific Auto-da-fé at Mani, systematically burning countless Maya codices containing astronomical, initiatic, and spiritual knowledge, condemning them as "superstition and lies of the devil." The indigenous priests of Central America were targeted, tortured, and killed for maintaining the same biological science of consciousness that Theodosius had purged in Greece.

Islamic Mysticism and Modern Suppression

Within the Islamic world, practitioners of Sufi orders who utilized techniques to achieve ma'rifa (direct gnosis) outside of the rigid exoteric legalism of the state faced similar brutality. The execution of the Sufi mystic Al-Hallaj in 922 CE for publicly declaring his experiential union with the divine stands as a stark historical example of the institutional intolerance for individuals who successfully bypassed the priest-class monopoly.

This suppression pattern continued into the modern era, culminating in the United States' Controlled Substances Act of 1970. Entirely ignoring the NEUROPLASTIC and therapeutic realities of these sacraments, the government classified them as Schedule I substances. As explicitly admitted by Nixon's domestic policy chief John Ehrlichman in a 1994 interview, published by Dan Baum in Harper's Magazine in 2016,[16] the criminalization of these compounds was a deliberate political tool designed to target, disrupt, and criminalize the anti-war left and minority communities. HSRP-036

The pattern of suppression is not a story about decadence, and it should not be told as one. Joseph Tainter[35], whose account of civilizational collapse remains the standard one, surveyed eleven families of explanation and filed every virtue-decline argument under "mystical factors" — the category containing Spengler, Toynbee, Gibbon, and anything non-quantifiable. He rejected the lot. In his model, the loss of cultural and artistic investment is a SYMPTOM of collapse, listed among its manifestations, not a cause preceding it. HSRP-376

But Tainter supplies a mechanism for suppression elsewhere in the same book, and it is a better one. Describing how complex societies establish legitimacy, he notes that every complex society has an official religion, and that sacred legitimization "provides a binding framework until real vehicles of power have been consolidated. Once this has been achieved the need for religious integration declines, and indeed conflict between secular and sacred authorities may thereafter ensue."

That is not decline. It is consolidation. A state that has finished building its own instruments of power no longer requires the sacred authority that legitimated its founding — and acquires a reason to contend with it. The fourteen documented suppression events across seventeen centuries fit that description far better than they fit a narrative of moral decay. HSRP-011 HSRP-065

What follows from suppression, on Tainter's own account, is not collapse directly. It is the loss of the cheaper of the two mechanisms a state has for holding a society together.

By locking a population into states of unyielding PV (what Fromm termed "institutional necrophilia"), empires destroy their internal capacity for psychological adaptation, innovation, and resilience. HSRP-041 A vital reminder must be made: suppressing the sacraments that align the brain and restore the capacity to reason is not the way to advance and protect your society or nation; rather, it is the exact mechanism by which a civilization ensures its own terminal decline.

The Societal Paradox: The Cultural Championing of Alcohol

The legal and cultural architecture of modern society presents a profound, deadly paradox: while entheogenic sacraments that promote neuroplasticity and cognitive restoration are violently suppressed and heavily penalized, alcohol—a known neurotoxic solvent—is championed, subsidized, and deeply embedded in the cultural fabric. HSRP-068

Alcohol functions in direct biological opposition to entheogens. Where psychedelics increase BDNF, promote dendritic spine growth, and reopen critical periods for learning and emotional development, alcohol functions as a broad-spectrum central nervous system depressant, acting in part through extrasynaptic GABA-A receptors.[14] It causes cumulative neurodegeneration, reduces cortical volume, and severely impairs the prefrontal cortex, heavily cementing the very cognitive rigidities and PV structures that entheogens dissolve. HSRP-297

Furthermore, the addictive profiles of these substances highlight the absurdity of current regulatory paradigms. Entheogens, by their true pharmacological nature, possess profound anti-addictive properties; they do not trigger the dopaminergic compulsion loops associated with drugs of abuse, and are currently the subject of breakthrough FDA clinical trials for treating severe substance use disorders.

Conversely, alcohol is highly addictive and broadly destructive. In a landmark 2010 multicriteria decision analysis published in The Lancet by Professor David Nutt, Leslie King, and Lawrence Phillips, an expert panel evaluated 20 different drugs based on 16 criteria measuring harm to the individual and harm to society.[15] The results were unequivocal: alcohol was ranked as the single most harmful drug in the United Kingdom, achieving an overall harm score of 72 out of 100, significantly outpacing heroin (55), crack cocaine (54), and methamphetamine (33). In stark contrast, entheogenic substances like psilocybin mushrooms and LSD ranked at the absolute bottom of the harm scale, with scores under 10.

Psychedelic-induced psychosis is rare: roughly 0.002% at population level, 0.2% in uncontrolled trials, 0.6% in randomised controlled trials, and 3.8% in people with existing schizophrenia. HSRP-282

Sabé et al., Molecular Psychiatry 30:1223 (2025)[18]

Transition from hallucinogen-induced psychosis to schizophrenia is estimated at 26% (CI 14–43%), which sits below cannabis at 34% (CI 25–46%, and 46–47% in national registers) and near the all-substance pooled rate of 25%. HSRP-283

Schizophrenia Bulletin 46(3):505 (2020)[19]; American Journal of Psychiatry (2018)[20]; Niemi-Pynttäri et al., register study of 18,478 Finnish inpatient cases[21]

Five caveats, without which this comparison does not hold: these are conditional rates, not population rates; exposure prevalence differs enormously between the two substances; per-exposure incidence has not been established; jurisdictions vary; and the hallucinogen estimate rests on three studies. PROBABLE, with the caveats stated

The culture actively champions a highly addictive substance that physically degenerates the brain and damages society, while simultaneously vilifying and criminalizing the exact substances proven by science to heal the mind. This regulatory asymmetry is a clear indicator of institutional necrophilia, a system seeking to maintain compliance through the cognitive impairment of its populace rather than fostering autonomous, reasoned flourishing. HSRP-296

Conclusion

The vast tapestry of human religious history is not a collection of isolated, competing superstitions; it is the fragmented, culturally veiled inheritance of a single, ancient biological science. The sacramental use of entheogens—from the kykeon of Greece and the blue lotus of Egypt, to the ayahuasca of the Amazon and modern synthesized prodrugs like 4-AcO-DMT—represents a universally applied technology designed to dismantle the rigid, ego-defensive architecture of the uninitiated mind.

These sacraments do not share a receptor. LSD and psilocybin act through 5-HT2A; ketamine works through glutamatergic systems; ibogaine, muscimol and the Egyptian preparation have their own profiles, as the table above records. The researchers who established the shared effect state plainly that a unifying mechanism remains unknown. HSRP-279

What they share is not a molecular door but an outcome. Each reopens a critical period for social reward learning, for a duration proportional to how long its subjective effects last in humans, and the reopening runs through restored oxytocin signalling in the nucleus accumbens and a reorganisation of the extracellular matrix. HSRP-278

That is a better result for this account than a shared receptor would have been. A single receptor would make the effect the property of one chemical family. A shared functional outcome, reached by four different pharmacological routes, is what makes the traditions' independent convergence on unrelated plants intelligible. They were not all finding the same molecule. They were finding the same door, restoring the individual's capacity to reason and allowing them to directly and experientially "come to know god." HSRP-374

All worldly religions are the continuation of this ancient tradition, their original esoteric power having been systematically corrupted into exoteric forms utilized by authoritarian institutions for social control. See: CHRISTIANITY, ISLAM and other sections under the RELIGION tab above. The historical suppression of these sacraments—from the Roman Senate's execution of the Bacchic initiates to the Spanish Inquisition's burning of Maya codices and the modern war on drugs—is the documented reflex of fragile power structures terrified of an awakened, unconditioned populace. Yet, as the ruins of Rome and the collapse of Bronze Age empires attest, silencing the technologies of cognitive restoration ensures civilizational collapse. Protecting the future of society requires abandoning the hypocritical championing of neurotoxic agents like alcohol, and acknowledging the profound medical, historical, and spiritual reality of the NEUROPLASTIC sacraments that have guided human cognitive evolution since antiquity.

And let us not forget for good measure, that the primary author of the declaration was known to personally hold knowledge of this pattern of collapse as detailed by C. F. Volney in his work (The Ruins, 1791) HSRP-042 by way of the observation that he personally translated it from French to English, where ultimately, the United States from its inception bears the hallmark of a legislative intent at its founding as detailed in the Declaration of Independence to operate in avoidance of this collapse as required by the tenets of NATURAL LAW, with the nation holding an omnipresent and affirmative legal obligation to forever sanctify and guard the availability of these ancient practices of restoring biophilic qualities at a civilization-wide and individual scale. See also YOUR DUTY.

This is for informational purposes only.

References

Entries marked OA have a free full-text route. BORROW requires a free Internet Archive account. PAYWALLED entries show abstracts only for most readers.

  1. Quirk, G.J., Repa, J.C. & LeDoux, J.E. Neuron 15(5):1029–1039 (1995). OA
  2. Mendez-Bertolo, C. et al. Nature Neuroscience 19:1041–1049 (2016). PAYWALLED
  3. "Rapid Processing of Invisible Fearful Faces in the Human Amygdala." J. Neuroscience 43(8):1405 (2023). OA
  4. Pessoa, L. & Adolphs, R. Nature Reviews Neuroscience 11:773–783 (2010). OA
  5. Tanasi, D., van Oppen de Ruiter, B.F., Florian, F. et al. "Multianalytical investigation reveals psychotropic substances in a ptolemaic Egyptian vase." Scientific Reports 14:27891 (2024). PMCID PMC11561246 OA
  6. Siegel, J.S., Subramanian, S., Perry, D. ... Nicol, G.E. & Dosenbach, N.U.F. "Psilocybin desynchronizes the human brain." Nature 632(8023):131–138 (2024). PMID 39020167 · PMCID PMC11291293 OA
  7. Nardou, R., Sawyer, E., Song, Y.J. et al. "Psychedelics reopen the social reward learning critical period." Nature 618(7966):790–798 (2023). PMCID PMC10284704 OA
  8. Cherian, K.N. et al. "Magnesium-ibogaine therapy in veterans with traumatic brain injuries." Nature Medicine 30(2):373–381 (2024). PMCID PMC10878970 OA
    See also: "Magnesium-ibogaine therapy effects on cortical oscillations and neural complexity." Nature Mental Health 3:918–931 (2025).
  9. Moliner, R., Girych, M., Brunello, C.A. ... Castren, E. "Psychedelics promote plasticity by directly binding to BDNF receptor TrkB." Nature Neuroscience 26(6):1032–1041 (2023). PMCID PMC10244169 OA
  10. Shao, L.-X. et al. "Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo." Neuron 109(16):2535–2544 (2021). PMCID PMC8376772 OA
  11. Vargas, M.V. et al. "Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors." Science 379(6633):700–706 (2023). PAYWALLED
  12. Ly, C. et al. "Psychedelics Promote Structural and Functional Neural Plasticity." Cell Reports 23:3170–3182 (2018). OA
  13. Carhart-Harris, R.L. & Friston, K.J. "REBUS and the Anarchic Brain." Pharmacological Reviews 71(3):316–344 (2019). PMCID PMC6588209 OA — CC BY
  14. Wallner, M., Hanchar, H.J. & Olsen, R.W. "Ethanol enhances alpha4beta3delta and alpha6beta3delta GABA-A receptors at low concentrations known to affect humans." PNAS 100(25):15218–15223 (2003). PMCID PMC299963 OA
  15. Nutt, D.J., King, L.A. & Phillips, L.D. "Drug harms in the UK: a multicriteria decision analysis." The Lancet 376(9752):1558–1565 (2010). PMID 21036393 PAYWALLED
    See also: van Amsterdam, J. & van den Brink, W. "Ranking of drugs: a more balanced risk-assessment." Lancet 376(9752):1524–1525 — response in the same issue.
  16. Baum, D. "Legalize It All: How to win the war on drugs." Harper's Magazine, April 2016 (source of the Ehrlichman quotation, from a 1994 interview). OA
  17. Muraresku, B.C. The Immortality Key: The Secret History of the Religion with No Name (St. Martin's Press, 2020). NO VERIFIED URL.
  18. Sabé, M., Sulstarova, A., Glangetas, A., De Pieri, M., Mallet, L., Curtis, L., Richard-Lepouriel, H., Penzenstadler, L. ... Kirschner, M. "Reconsidering evidence for psychedelic-induced psychosis: an overview of reviews, a systematic review, and meta-analysis of human studies." Molecular Psychiatry 30(3):1223–1255 (2025). PMID 39592825 · PMCID PMC11835720 OA — CC BY
    The 3.8% figure is from uncontrolled trials that included individuals with schizophrenia.
  19. Murrie, B., Lappin, J., Large, M. & Sara, G. "Transition of Substance-Induced, Brief, and Atypical Psychoses to Schizophrenia: A Systematic Review and Meta-analysis." Schizophrenia Bulletin 46(3):505–516 (2020). PMID 31618428 · PMCID PMC7147575 OA
    Source of the 26% (hallucinogen, three studies), 34% (cannabis) and 25% (all-substance pooled) transition rates.
  20. Starzer, M.S.K., Nordentoft, M. & Hjorthøj, C. "Rates and Predictors of Conversion to Schizophrenia or Bipolar Disorder Following Substance-Induced Psychosis." American Journal of Psychiatry 175(4):343–350 (2018). PMID 29179576 PAYWALLED
    Danish national register. The 47.4% cannabis figure is conversion to schizophrenia or bipolar disorder combined, not schizophrenia alone.
  21. Niemi-Pynttäri, J.A., Sund, R., Putkonen, H., Vorma, H., Wahlbeck, K. & Pirkola, S.P. "Substance-induced psychoses converting into schizophrenia: a register-based study of 18,478 Finnish inpatient cases." Journal of Clinical Psychiatry 74(1):e94–e99 (2013). PMID 23419236
    Eight-year cumulative risk of conversion to schizophrenia-spectrum disorder after cannabis-induced psychosis: 46% (95% CI 35–57%).
  22. Wasson, R.G., Hofmann, A. & Ruck, C.A.P. The Road to Eleusis: Unveiling the Secret of the Mysteries (Harcourt Brace Jovanovich, 1978). NO VERIFIED URL.
  23. Burkert, W. Ancient Mystery Cults (Harvard University Press, 1987), p. 108. NO VERIFIED URL.
  24. Juan-Tresserras, J. "Estudis dels residus orgànics per a la identificació de possibles ritus i ofrenes." In Mas Castellar de Pontós (Alt Empordà): un complex arqueològic d'època ibèrica (Excavacions 1990–1998), Museu d'Arqueologia de Catalunya–Girona, 2002, pp. 548–556. NO VERIFIED URL.
    Earlier synthesis: Juan-Tresserras, J. "La arqueología de las drogas en la Península Ibérica: una síntesis de las recientes investigaciones arqueobotánicas." Complutum 11:261–274 (2000). The finds are fragments of ergot, not a chemical detection of ergot alkaloids.
  25. Antonopoulos, R.K., Dadiotis, E., Ioannidis, K., Cheilari, A., Mitsis, V., García-Campaña, A.M., Gámiz-Gracia, L., Hernández-Mesa, M., Narváez, A., Hoffman, M.A., Ruck, C.A.P., Gonou-Zagou, Z., Aligiannis, N. & Magiatis, P. "Investigating the psychedelic hypothesis of kykeon, the sacred elixir of the Eleusinian Mysteries." Scientific Reports 16:8757 (2026). OA — CC BY
    Source of the dental calculus detail and of the statement that no systematic residue analysis has ever been permitted at Eleusis. The paper's own work is a laboratory test of ergot detoxification, not an excavation find.
  26. Novum Testamentum Graece (Nestle–Aland): Matthew 19:28 and Titus 3:5. Edition and year not yet recorded. NO VERIFIED URL.
    Strong's Greek Concordance G3824 (palingenesia) records two occurrences, Matthew 19:28 and Titus 3:5. Register: https://worldfreedomcore.com/hsrp-research-notes#SRC-485
  27. Gospel of Philip (Nag Hammadi Codex II,3), trans. Wesley W. Isenberg, in The Nag Hammadi Library.
    "The chrism is superior to baptism." The text names five mysteries: "a baptism and a chrism and a eucharist and a redemption and a bridal chamber."
  28. Gonzales v. O Centro Espírita Beneficente União do Vegetal, 546 U.S. 418 (2006).
    Decided 21 February 2006, opinion by Chief Justice Roberts: the Government failed to demonstrate a compelling interest under the Religious Freedom Restoration Act in barring the UDV's sacramental use of hoasca.
  29. Clement of Alexandria, Stromateis 3.3.17, quoting Pindar (fragment 137) on the Eleusinian mysteries.
    That translation reads: "Blessed is he who has seen before he goes under the earth; for he knows the end of life and knows also its divine beginning."
  30. Dioscorides, De Materia Medica 5.81 (mandrake wine), trans. T. A. Osbaldeston & R. P. A. Wood (Ibidis Press, Johannesburg, 2000), pp. 778–779. ISBN 0-620-23435-0. NO VERIFIED URL.
    A recipe: mandrake root bark steeped in must for three months. A measured dose "brings one into a heavy, deep sleep", moderate use "takes away the sense of pain", and one winecupful "kills".
  31. Jerome, Epistle 107 (to Laeta), 2, listing the seven Mithraic grades: corax, nymphius, miles, leo, Perses, heliodromus, pater.
  32. Mithraeum of Felicissimus, Ostia Antica: floor mosaic of the seven grades, each paired with its planetary symbol (Vermaseren, CIMRM 299).
  33. Jones, N.T., Wagner, L., Hahn, M.C.P., Scarlett, C.O. & Wenthur, C.J. "In vivo validation of psilacetin as a prodrug yielding modestly lower peripheral psilocin exposure than psilocybin." Frontiers in Psychiatry 14:1303365 (2023). PMID 38264637 · PMCID PMC10804612 OA
    In mice given equimolar doses, psilacetin fumarate produced about 70% of the psilocin exposure of psilocybin; the half-life of psilocin was about 30 minutes from either compound.
  34. El-Seedi, H.R., De Smet, P.A., Beck, O., Possnert, G. & Bruhn, J.G. "Prehistoric peyote use: alkaloid analysis and radiocarbon dating of archaeological specimens of Lophophora from Texas." Journal of Ethnopharmacology 101(1–3):238–242 (2005). PMID 15990261
    Two peyote buttons from Shumla Cave No. 5 on the Rio Grande, radiocarbon-dated to 3780–3660 BC, with mescaline identified in both. Earlier report: Bruhn, J.G., De Smet, P.A., El-Seedi, H.R. & Beck, O. "Mescaline use for 5700 years." The Lancet 359(9320):1866 (2002). https://worldfreedomcore.com/hsrp-research-notes#SRC-509
  35. Tainter, J.A. The Collapse of Complex Societies (Cambridge University Press, 1988). ISBN 0-521-34092-6. Legitimacy and coercion at pp. 27-28; the eleven theories at ch. 3, pp. 42-90; "mystical factors" at pp. 74-86. NO VERIFIED URL.
  36. Doss, M.K., Považan, M., Rosenberg, M.D., Sepeda, N.D., Davis, A.K., Finan, P.H., Smith, G.S., Pekar, J.J., Barker, P.B., Griffiths, R.R. & Barrett, F.S. "Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder." Translational Psychiatry 11:574 (2021). PMID 34750350 · PMCID PMC8575795 · DOI 10.1038/s41398-021-01706-y · ClinicalTrials.gov NCT03181529 OA SRC-551
  37. Pokorny, T., Duerler, P., Seifritz, E., Vollenweider, F.X. & Preller, K.H. "LSD acutely impairs working memory, executive functions and cognitive flexibility but not risk-based decision-making." Psychological Medicine 50:2255–2264 (2020). PMID 31500679 SRC-552
  38. Barrett, F.S., Doss, M.K., Sepeda, N.D., Pekar, J.J. & Griffiths, R.R. "Emotions and brain function are altered up to one month after a single high dose of psilocybin." Scientific Reports 10 (2020). PMCID PMC7010702 OA SRC-553